ABT-751

DB12254InvestigationalSmall molecule

ABT-751 has been investigated for the treatment of Lung Cancer, Non-Small Cell Lung Cancer, and Non-Small-Cell Lung Cancer.

Chemical structure of ABT-751
Mechanism
Curator reviewed
Formula / weight
C18H17N3O4S · 371.41 g/mol (avg)
Also known as
N-[2-(4-hydroxyanilino)-3-pyridinyl]-4-methoxybenzenesulfonamide · N-[2-(4-hydroxyanilino)pyridin-3-yl]-4-methoxybenzenesulfonamide · N-[2-[(4-hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonamide
Code names
ABT-751 · E-7010 · NSC-742134

Resolves to

Compound
UNIIWDT5V5OB9FCAS141430-65-1ChEMBLCHEMBL20684ChEBI95043PubChem3035714
Structure
InChIKeyURCVCIZFVQDVPM-UHFFFAOYSA-NSMILESCOC1=CC=C(C=C1)S(=O)(=O)NC1=C(NC2=CC=C(O)C=C2)N=CC=C1
Targets
P07437TUBB

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
11Clinical trialsPhase, status and sponsor resolved per trial
Sign in
10+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with ABT-751, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In